Functional significance of a C-->A polymorphism in intron 1 of the cytochrome P450 CYP1A2 gene tested with caffeine.
about
Applications of CYP450 testing in the clinical settingReview of the use of the glutamate antagonist riluzole in psychiatric disorders and a description of recent use in childhood obsessive-compulsive disorderSmoking and tardive dyskinesia: lack of involvement of the CYP1A2 geneCytochrome P450 1A2 (CYP1A2) activity and risk factors for breast cancer: a cross-sectional studyThe role of genetic polymorphisms in environmental health.Coffee, Genetic Variants, and Parkinson's Disease: Gene-Environment InteractionsPharmacogenetics of antidepressants and antipsychotics: the contribution of allelic variations to the phenotype of drug responseVariability of cytochrome P450 1A2 activity over time in young and elderly healthy volunteersCYP1A2 rs762551 polymorphism contributes to cancer susceptibility: a meta-analysis from 19 case-control studiesWhere Failure Is Not an Option -Personalized Medicine in AstronautsBreast density and polymorphisms in genes coding for CYP1A2 and COMT: the Multiethnic Cohort.Case-only study of interactions between metabolic enzymes and smoking in colorectal cancerBiomonitoring of complex occupational exposures to carcinogens: the case of sewage workers in Paris.The Safety of Ingested Caffeine: A Comprehensive Review.Coffee consumption and CYP1A2 genotype in relation to bone mineral density of the proximal femur in elderly men and women: a cohort study.Gene-Environment Interaction in Parkinson's Disease: Coffee, ADORA2A, and CYP1A2.Investigation of the major cytochrome P450 1A2 genetic variant in a healthy Tibetan population in China.Polymorphisms of caffeine metabolism and estrogen receptor genes and risk of Parkinson's disease in men and women.Caffeine, selected metabolic gene variants, and risk for neural tube defects.Review of the pharmacokinetics, pharmacogenetics, and drug interaction potential of antidepressants: focus on venlafaxine.Genetics of caffeine consumption and responses to caffeine.Single nucleotide polymorphisms, metabolic activation and environmental carcinogenesis: why molecular epidemiologists should think about enzyme expression.Caffeine consumption during pregnancy and risk of preterm birth: a meta-analysis.Genetic variability of drug-metabolizing enzymes: the dual impact on psychiatric therapy and regulation of brain function.Influence of environmental and genetic factors on CYP1A2 activity in individuals of South Asian and European ancestry.Polymorphisms of cytochrome P4501A2 and N-acetyltransferase genes, smoking, and risk of pancreatic cancer.Genetic variation in melatonin pathway enzymes in children with autism spectrum disorder and comorbid sleep onset delay.CYP1A1/2 haplotypes and lung cancer and assessment of confounding by population stratification.Pharmacogenetics of asthma.Cytochrome P450 polymorphisms and response to antipsychotic therapy.BJCP 40th anniversary: moving forward, looking back.Pharmacogenetics and antipsychotics: therapeutic efficacy and side effects predictionCYP1A2*1F and GSTM1 alleles are associated with susceptibility to porphyria cutanea tarda.Sequence variants at CYP1A1-CYP1A2 and AHR associate with coffee consumptionquantitative assessment of the influence of cytochrome P450 1A2 gene polymorphism and colorectal cancer riskReceptor pharmacogenetics: relevance to CNS syndromesStructure, function, regulation and polymorphism and the clinical significance of human cytochrome P450 1A2.Pharmacogenetics of antidepressantsPharmacogenetics of the major polymorphic metabolizing enzymes.CYP1A2 polymorphism -1545C > T (rs2470890) is associated with increased side effects to clozapine.
P2860
Q24621760-140C86C0-326E-4A3C-A223-D5F30C84ADCAQ24629266-AC65B076-95C9-48DB-8B63-22EBC985F220Q24670466-CEDDE2F3-6699-4529-995B-0F64E61333CCQ24806052-86BB6A8A-1EF2-485C-9D25-AF2E363549BEQ24815139-499A0211-33A6-4C10-A340-DCE2D22B8D8AQ26852456-D5F68644-ECDC-4969-AD27-B6CA9620A6C3Q28252209-F6D07C34-7015-4610-98B2-F1672A7E7709Q28365919-0EB37520-4F46-427A-8CE1-D60D0084DA0EQ28392197-BAD0E509-706E-45CA-8E57-FC8B02510C1AQ28550427-C11CBD94-4A2F-48B3-95B6-A8E9CBB86408Q33273465-91EB956F-66F8-4B64-B56F-9AB3648DD3A0Q33289542-85C689A3-A93E-43F1-810F-971E063816E9Q33322926-70DD35CD-4C05-4351-9B7C-38632FDB7CCEQ33729422-918E6B3F-AB3C-4105-889A-F47A623A848DQ33741759-9BBF480E-697F-4AE3-AB20-3F1FAD223F8FQ33782664-E4FB1592-3033-4A1F-A17D-2139BAF3E53BQ33828034-D8BA6EEA-F76E-4611-9027-31093112248FQ34044101-94DA846E-63DE-486F-8956-5307E9DEC706Q34051331-CC79ED95-562C-4B39-B4A0-8D94AEEB7D2EQ34093694-F5358859-D2C3-4EBD-9EDC-810F1253159EQ34119748-9A2D8A6D-5359-4FBE-9131-D580CBE19F92Q34142068-3E85E88A-CCFA-440E-B117-07CA35EC483CQ34196253-2642BA41-A2BD-4B8F-8B6C-604D8A03EE17Q34273354-5A87123B-8F92-4775-A1B7-BF9C2787CFF8Q34297580-C4E7DA2C-B3C0-468B-B888-45C285C6554CQ34311814-CC156B7D-4991-4899-95F1-E1264FD9D541Q34430684-B46BC902-94C5-4953-8062-D94C12D2D7C7Q34477176-DDEB8995-606A-4395-AC2D-FE7B4437AE0FQ34534425-F62FA041-1218-4728-82DB-B5FF85BDC626Q34612118-38378C39-73A4-4B81-9450-233139C80897Q34635476-A2783587-48D6-45C6-AE3A-CBBE5DB5FF4EQ34676533-830BAEB2-10A0-411D-ABFD-9EF03A4536DCQ34699532-68B7D434-F206-4FA9-A879-8EF2FBA27D3CQ34829535-BBA94410-4D47-40E7-85B6-A9F2E2F2921FQ34949682-86E6B579-DEB1-45C8-9B27-7FCF250DC05AQ34976865-EE760EEE-0038-4CCA-BC1A-BD058010CF0AQ35015993-71DEB578-5D6D-4128-ACFA-9E62AF27D88EQ35026088-C02B46A2-C3A0-4223-A13C-AA50383A3BDEQ35067187-AB36A15F-0D0E-4F10-BFA0-E4776E4E091BQ35098697-EE9C328B-0672-4673-AEE4-C6716D02205A
P2860
Functional significance of a C-->A polymorphism in intron 1 of the cytochrome P450 CYP1A2 gene tested with caffeine.
description
1999 nî lūn-bûn
@nan
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
1999年论文
@zh
1999年论文
@zh-cn
name
Functional significance of a C ...... 1A2 gene tested with caffeine.
@en
type
label
Functional significance of a C ...... 1A2 gene tested with caffeine.
@en
prefLabel
Functional significance of a C ...... 1A2 gene tested with caffeine.
@en
P2093
P2860
P1476
Functional significance of a C ...... 1A2 gene tested with caffeine.
@en
P2093
P2860
P304
P356
10.1046/J.1365-2125.1999.00898.X
P407
P577
1999-04-01T00:00:00Z